ScholarIQanswers from OpenAlex
Universitäts-Herzzentrum Freiburg-Bad Krozingen
InstitutionResearch output, impact & collaborations
Universitäts-Herzzentrum Freiburg-Bad Krozingen is a institution indexed in ScholarIQ from OpenAlex.
What is known about Universitäts-Herzzentrum Freiburg-Bad Krozingen?
ScholarIQrecord summary
Universitäts-Herzzentrum Freiburg-Bad Krozingen is a research organisation in Bad Krozingen, DE. OpenAlex records 4,719 works and 478,120 citations for it. 1,135 researchers list it as their most recent affiliation.
How many works does Universitäts-Herzzentrum Freiburg-Bad Krozingen have?
ScholarIQindexed works
Universitäts-Herzzentrum Freiburg-Bad Krozingen has 4,719 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Universitäts-Herzzentrum Freiburg-Bad Krozingen have?
ScholarIQcitation count
Universitäts-Herzzentrum Freiburg-Bad Krozingen has 478,120 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Universitäts-Herzzentrum Freiburg-Bad Krozingen?
ScholarIQresearcher count
Universitäts-Herzzentrum Freiburg-Bad Krozingen has 1,135 researchers in the ScholarIQ index.
What is the average h-index at Universitäts-Herzzentrum Freiburg-Bad Krozingen?
ScholarIQavg h-index
Universitäts-Herzzentrum Freiburg-Bad Krozingen has an average h-index of 89.5 in OpenAlex.
What is the ROR of Universitäts-Herzzentrum Freiburg-Bad Krozingen?
ScholarIQror
The ROR for Universitäts-Herzzentrum Freiburg-Bad Krozingen is on the source record.
What is the OpenAlex record for Universitäts-Herzzentrum Freiburg-Bad Krozingen?
ScholarIQopenalex
The OpenAlex for Universitäts-Herzzentrum Freiburg-Bad Krozingen is on the source record.
Who are the most-cited researchers behind Universitäts-Herzzentrum Freiburg-Bad Krozingen?
ScholarIQtop researchers by citations
What are the most-cited papers on Universitäts-Herzzentrum Freiburg-Bad Krozingen?
ScholarIQmost cited works
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
Hölger Thiele, Uwe Zeymer, Franz‐Josef Neumann, Mirosław Ferenc, Hans‐Georg Olbrich, Jörg Hausleiter, Antoinette de Waha, Gert Richardt, Marcus Hennersdorf, Klaus Empen, Georg Fuernau, Steffen Desch, Ingo Eitel, Rainer Hambrecht, Bernward Lauer, Michael Böhm, Henning Ebelt, Steffen Schneider, Karl Werdan, Gerhard Schüler
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
David E. Kandzari, Michael Böhm, Felix Mahfoud, Raymond R. Townsend, Michael A. Weber, Stuart Pocock, Konstantinos Tsioufis, Dimitrios Tousoulis, James W. Choi, Cara East, Sandeep Brar, Sidney A. Cohen, Martin Fahy, Garrett Pilcher, Kazuomi Kario, Jiro Aoki, Bryan Batson, Michael Böhm, James W. Choi, Debbie L. Cohen, George Dangas, Shukri David, Justin E. Davies, Chandan Devireddy, David Kandzari, Kazuomi Kario, David P. Lee, Philipp Lurz, Vasilios Papademetriou, Manesh R. Patel, Kiritkumar Patel, Roland E. Schmieder, Andrew S.P. Sharp, Jasvindar Singh, Konstantinos Tsioufis, Antony Walton, Thomas Weber, Joachim Weil, Thomas Zeller, Khaled M. Ziada, Kengo Tanabe, Robert B. Wilkins, Felix Mahfoud, Cara East, Robert Wilensky, Johanna Contreras, Susan Steigerwalt, Neil Chapman, Janice P. Lea, Denise Reedus, Satoshi Hoshide, Adrian Ma, Karl Fengler, Ping Li, Laura P. Svetkey, Anjani Rao, Axel Schmid, Anthony Watkinson, Angela L. Brown, Dimitrios Tousoulis, Ingrid Hopper, Markus Suppan, Tolga Agdirlioglu, Elias Noory, Craig A. Chasen
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Raymond R. Townsend, Felix Mahfoud, David E. Kandzari, Kazuomi Kario, Stuart Pocock, Michael A. Weber, Sebastian Ewen, Konstantinos Tsioufis, Dimitrios Tousoulis, Andrew S.P. Sharp, Anthony Watkinson, Roland E. Schmieder, Axel Schmid, James W. Choi, Cara East, A. Walton, Ingrid Hopper, Debbie L. Cohen, Robert Wilensky, David P. Lee, Adrian Ma, Chandan Devireddy, Janice P. Lea, Philipp Lurz, Karl Fengler, Justin E. Davies, Neil Chapman, Sidney A. Cohen, Vanessa DeBruin, Martin Fahy, Denise Jones, Martin T. Rothman, Michael Böhm, Jiro Aoki, Bryan Batson, Michael Böhm, James W. Choi, Debbie L. Cohen, George Dangas, Shukri David, Justin E. Davies, Chandan Devireddy, David Kandzari, Kazuomi Kario, David P. Lee, Philipp Lurz, Manesh R. Patel, Kiritkumar Patel, Roland E. Schmieder, Andrew S.P. Sharp, Jasvindar Singh, Konstantinos Tsioufis, A. Walton, Thomas Weber, Joachim Weil, Thomas Zeller, Khaled M. Ziada, Kengo Tanabe, Robert B. Wilkins, Felix Mahfoud, Cara East, Robert Wilensky, Johanna Contreras, Susan Steigerwalt, Neil Chapman, Janice P. Lea, Denise Reedus, Satoshi Hoshide, Adrian Ma, Karl Fengler, Laura P. Svetkey, Anjani Rao, Axel Schmid, Anthony Watkinson, Angela L. Brown, Dimitrios Tousoulis, Ingrid Hopper, Markus Suppan, Tolga Agdirlioglu, Elias Noory, Craig A. Chasen
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease
Kenneth Rosenfield, Michael R. Jaff, Christopher J. White, Krishna J. Rocha‐Singh, Carlos Mena‐Hurtado, D. Christopher Metzger, Marianne Brodmann, Ernst Pilger, Thomas Zeller, Prakash Krishnan, Roger Gammon, Stefan Müller‐Hülsbeck, Mark R. Nehler, James F. Benenati, Dierk Scheinert
Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease
Michael D. Dake, Gary M. Ansel, Michael R. Jaff, Takao Ohki, Richard R. Saxon, H. Bob Smouse, Thomas Zeller, Gary S. Roubin, Mark W. Burket, Yazan Khatib, S.A. Snyder, Anthony Ragheb, Jennifer White, Lindsay Machan
How much of the research on Universitäts-Herzzentrum Freiburg-Bad Krozingen is open access?
ScholarIQopen access share
36%OPEN ACCESS